Andrea H. Roe, MD, MPH
Obstetrics and Gynecology
Accepting new patients
Sees patients age 15 to 65
Penn Health for Women Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Assistant Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating

149 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
perfect experience
October 2025
she was kind and nonjudgmental
October 2025
dr. roe was thorough and did a great job of easing my mind and fears
September 2025
great bedside

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Roe is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Alpert A, Bell S, Kaur, P, Antonacci C, Gutman S, Roe AH Empowering Future Clinicians: Trauma-informed Care Training in an Ob/Gyn Clerkship. Scheduled to present a poster. , CREOG & APGO Annual Meeting, Seattle, WA: 2026

Raghunathan S, Roe AH, Gutman S, Shah DK Classroom to Clerkship: Impact of Vertically Integrated Didactics on OBGYN Clerkship. Scheduled to present a poster. , CREOG & APGO Annual Meeting, Seattle, WA: 2026

Nguyen AT, Nandi P, Roe AH, Pecker LH, Whiteman MK, Tepper NK, Curtis KM Safety of hormonal contraception among women with sickle cell disease: an updated systematic review. , Contraception doi: 10.1016/j.contraception.2025.111275, 31:111275: 2025, Online ahead of print

Pineles BL, Jain R, Kazmerski TM, Taylor-Cousar JL, Chambers C, Foil KL, Roe AH, Szentpetery SE Pregnancy in Patients With Cystic Fibrosis. , Obstet Gynecol doi:10.1097/AOG.0000000000006084: 2025 Epub head of print

Braun E, McVay K, Koelper N, Ali N, Gollomp K, Roe AH Induced and spontaneous abortion outcomes among individuals with sickle cell disease. , Contraception doi: 10.1016/j.contraception.2025.111052, 152:111052: 2025

Wu M, West NE, Hsu C, Kahn FN, Chin J, Walker P, Roe AH, Uluer A, Taylor-Cousar JL, Bray LA, Mody S, Kazmerski TM, Jain R, Aitken ML, Magaret AS, Godfrey E Concordance of cystic fibrosis related bone disease documentation in the CF Foundation Patient Registry , North American Cystic Fibrosis Conference: 2025

Barnidge M, Dysart K, Clausen E, Hadjiliadis D, Hong G, Roe A, Burris H. Severe maternal morbidity and preterm birth rates in pregnant women with cystic fibrosis , North American Cystic Fibrosis Conference: 2025

Chin J, Sarkar M, Magaret A, Hsu C, Walker P, Schwind E, Taylor-Cousar J, Ladores-Barrett S, Hadjiliadis D, Roe AH, Godfrey E Liver function among women with cystic fibrosis who use hormonal contraception (Poster). , European Congress on Menopause and Andropause: 2025

Creinin MD, Gawron LM, Roe AH, Blumenthal PD, Boraas CM, Hou MY, McNicholas C, Schreifels MJ, Peters K, Culwell K, Turok DK; Copper 175mm(2) IUD Phase 3 Clinical Investigator Group Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device. , Contraception, 143:110771: 2025

Lee IT, Wu J, Koelper N, Mumford SL, Barnhart KT, Roe AH Prediction of menstrual cycle phase using cross-sectional measurements of reproductive hormones. , Fertil Steril, 123(3):532-533: 2025